On March 1, 2017, the Georgia House of Representatives voted to approve House Bill 65, which would expand the number of qualifying conditions covered by the state’s limited medical marijuana program.
Tag Archives: Alzheimer’s Disease
SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.
LAS VEGAS, Oct. 12, 2016 /Weed Wire/ — Growblox Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC.
As Ohio’s new medical marijuana law goes into effect, stakeholders have more questions than answers, according to a Sept. 8, 2016, article by the Associated Press. The new law went into effect on Sept. 8, 2016, making Ohio the 25th state to have legalized medical marijuana, but Ohio does not have dispensaries at which qualified patients can buy it.
While marijuana may be the culprit of some short term memory loss, new research seems to suggest that an active chemical in the substance, THC, may be the key in the prevention and treatment of Alzheimer’s disease.